CCL3 and COVID-19: The relative gene expression levels of this inflammatory chemokine were higher in the abnormal spirometry group than in the normal group, suggesting that the MIP-1A-mediated antiviral immunity triggered in COVID-19 patients that progress to post-COVID-19 syndrome with abnormal spirometry is more persistent than in post-COVID-19 syndrome cases with normal spirometry.